- News Home
6 March 2014 1:04 pm ,
Vol. 343 ,
Antiretroviral drugs can protect people from becoming infected by HIV. But so-called pre-exposure prophylaxis, or PrEP...
Two studies show that eating a diet low in protein and high in carbohydrates is linked to a longer, healthier life, and...
Considered an icon of conservation science, researchers at World Wildlife Fund (WWF) headquarters in Washington, D.C.,...
The new atlas, which shows the distribution of important trace metals and other substances, is the first product of...
Early in April, the first of a fleet of environmental monitoring satellites will lift off from Europe's spaceport in...
Since 2000, U.S. government health research agencies have spent almost $1 billion on an effort to churn out thousands...
Magdalena Koziol, a former postdoc at Yale University, was the victim of scientific sabotage. Now, she is suing the...
- 6 March 2014 1:04 pm , Vol. 343 , #6175
- About Us
Company Nabbed in Sting With Bogus Study Stops Reviewing Trials
15 April 2009 1:33 pm
A company that gave ethics approval to a fake clinical trial has agreed to stop reviewing FDA-approved studies.
All studies of FDA-approved drugs and devices have to be approved by an institutional review board (IRB), a panel of experts that is supposed to make sure the people who volunteer for the study are protected. The company, Coast IRB in Colorado Springs, Colorado, is an example of a for-profit IRB.
Last month, the federal Government Accountability Office and a congressional committee revealed that Coast IRB had approved a fake study of a fictitious FDA-approved device. As part of an agreement with the FDA, up to 300 or so ongoing trials that the company had approved will stop enrolling new patients while the company improves its practices.